JNJ Johnson & Johnson Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

JNJ [NYSE]

Johnson & Johnson

Healthcare | Drug Manufacturers - General | USA

statements

Index	DJIA S&P500	P/E	22.21	EPS (ttm)	6.41	Insider Own	0.10%	Shs Outstand	2.63B	Perf Week	0.99%
Market Cap	373.52B	Forward P/E	15.73	EPS next Y	9.05	Insider Trans	-3.56%	Shs Float	2.63B	Perf Month	-3.67%
Income	17.17B	PEG	4.63	EPS next Q	1.47	Inst Own	70.80%	Short Float	0.52%	Perf Quarter	0.81%
Sales	82.73B	P/S	4.51	EPS this Y	0.50%	Inst Trans	-0.02%	Short Ratio	1.72	Perf Half Y	-2.08%
Book/sh	23.27	P/B	6.12	EPS next Y	17.19%	ROA	11.00%	Target Price	164.24	Perf Year	1.61%
Cash/sh	6.87	P/C	20.72	EPS next 5Y	4.80%	ROE	28.60%	52W Range	109.16 - 157.00	Perf YTD	-2.40%
Dividend	4.04	P/FCF	38.36	EPS past 5Y	-0.20%	ROI	17.30%	52W High	-9.32%	Beta	0.70
Dividend %	2.84%	Quick Ratio	1.00	Sales past 5Y	2.00%	Gross Margin	66.30%	52W Low	30.42%	ATR	2.71
Employees	132200	Current Ratio	1.30	Sales Q/Q	3.30%	Oper. Margin	23.50%	RSI (14)	47.90	Volatility	1.64% 1.89%
Optionable	Yes	Debt/Eq	0.45	EPS Q/Q	56.20%	Profit Margin	20.70%	Rel Volume	0.53	Prev Close	142.49
Shortable	Yes	LT Debt/Eq	0.41	Earnings	Jul 16 BMO	Payout	58.40%	Avg Volume	8.02M	Price	142.37
Recom	1.90	SMA20	0.40%	SMA50	-2.09%	SMA200	1.11%	Volume	4,228,318	Change	-0.08%

Apr-28-20

Downgrade

UBS

Buy → Neutral

$163 → $160

Apr-22-20

Upgrade

BofA/Merrill

Neutral → Buy

$150 → $175

Mar-05-20

Initiated

Citigroup

Buy

$163

Dec-19-19

Upgrade

Barclays

Equal Weight → Overweight

$173

Dec-17-19

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$145 → $170

Nov-20-19

Initiated

Cantor Fitzgerald

Overweight

$160

Oct-16-19

Upgrade

Atlantic Equities

Underweight → Neutral

Oct-11-19

Upgrade

Bernstein

Mkt Perform → Outperform

$155

Jul-12-19

Resumed

Credit Suisse

Outperform

$156

May-28-19

Initiated

Goldman

Buy

Jan-23-19

Reiterated

Barclays

Equal Weight

$137 → $135

Jul-12-18

Upgrade

Goldman

Sell → Neutral

Jun-27-18

Initiated

Bernstein

Mkt Perform

$129

Apr-23-18

Reiterated

Citigroup

Neutral

$146 → $134

Apr-18-18

Reiterated

Stifel

Hold

$145 → $135

Jan-24-18

Reiterated

Stifel

Hold

$142 → $145

Jan-12-18

Reiterated

Wells Fargo

Outperform

$155 → $160

Jan-02-18

Downgrade

JP Morgan

Overweight → Neutral

Oct-18-17

Reiterated

Stifel

Hold

$140 → $142

Oct-18-17

Reiterated

RBC Capital Mkts

Outperform

$144 → $147

Jul-10-20 12:49PM	Kiplinger's Weekly Earnings Calendar (7/13-7/17): JNJ, JPM, NFLX Kiplinger
10:01AM	FDA says to review side effect of GSK's multiple myeloma drug Reuters
09:00AM	Is JNJ Stock A Buy As Pharma Giant Speeds Up Coronavirus Vaccine Plans? Investor's Business Daily
07:43AM	Britain to set out its position on EU vaccine scheme later on Friday Reuters
Jul-09-20 04:07PM	Health Giant Johnson & Johnson On Deck To Report Here's What We Know Investor's Business Daily
03:01PM	Dividend Tide Turns, Barring a Second Wave. Heres How to Avoid a Wipeout. Barrons.com
01:34PM	U.S. planning for tens of millions of potential COVID-19 vaccine doses this fall - official Reuters
12:30PM	Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy? Zacks
11:44AM	Coronavirus vaccine makers to testify before U.S. House committee Reuters
09:00AM	Is ISRG Stock A Buy As The Robotic Surgery Giant Claws Back From A Low? Investor's Business Daily
07:04AM	3 Stocks I'll Be Buying When the Market Crashes Again Motley Fool
07:00AM	Prominent plaintiffs' firms sought government bailout to stay afloat Reuters
12:37AM	Nonprofits urge Johnson & Johnson to halt sales of Baby Powder globally Reuters
Jul-08-20 04:54PM	Nonprofits urge Johnson & Johnson to halt sales of Baby Powder globally Reuters
04:21PM	Potential COVID-19 vaccine not 'single solution' to pandemic, Johnson & Johnson CEO says Reuters
12:10PM	Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again Zacks
11:59AM	J&J's Cilag to sell up to 11.8 mln Idorsia shares Reuters
11:30AM	Where COVID-19 vaccine trials stand Yahoo Finance Video
11:25AM	Emergent BioSolutions Gets Deeper Into Covid-19 Deals Barrons.com
06:30AM	Is There a Coronavirus Vaccine Yet? Motley Fool
Jul-07-20 05:45PM	Johnson & Johnson (JNJ) Stock Moves -0.09%: What You Should Know Zacks
11:46AM	Emergent's (EBS) 5-Year Deal to Back J&J's Coronavirus Vaccine Zacks
06:00AM	U.S. government awards Novavax $1.6 billion for coronavirus vaccine Reuters
Jul-06-20 01:11PM	The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks Kiplinger
01:06PM	Jabil Inc. -- Moody's assigns Baa3 to Jabil's new senior notes Moody's
12:19PM	Catalent plant in Italy will help produce J&J's potential COVID-19 vaccine - minister Reuters
11:58AM	Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries PR Newswire
11:13AM	Johnson & Johnson cuts price of TB drug bedaquiline in poorer countries Reuters
08:38AM	3 Stocks I'm Never Selling Motley Fool
07:56AM	Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J MarketWatch
06:52AM	Emergent signs five-year deal backing J&J COVID-19 vaccine Reuters
06:51AM	Emergent to make drug substance for J&J's COVID-19 vaccine candidate Reuters
Jul-05-20 07:05PM	Which Company Is Most Likely to Reach $1 Trillion Next? Here Are Some Guesses. Barrons.com
07:21AM	10 Things to Do When the Stock Market Crashes Motley Fool
Jul-03-20 09:31AM	Johnson & Johnson Gets European Approval for Ebola Vaccine Zacks
Jul-02-20 10:03PM	Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses Reuters
05:35PM	Were Hedge Funds Right About Cutting Johnson & Johnson (JNJ)? Insider Monkey
04:37PM	The Number of Covid-19 Cases Is Rising. What Comes Next. Barrons.com
03:30PM	Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses Reuters
03:23PM	Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses Reuters
01:12PM	Pedal to the Metal Leads to Record Rebound GuruFocus.com
01:02PM	Keep an Eye on Royalty Pharma Stock, 2020s Biggest IPO InvestorPlace
10:04AM	Buy Opko Stock For Two Ways to Play the Ongoing Pandemic InvestorPlace
09:11AM	Will Legal Problems Bankrupt Johnson & Johnson? Motley Fool
Jul-01-20 09:46AM	New FDA Guidance May Not Allow Covid-19 Vaccine This Year, Analyst Says Barrons.com
08:26AM	Better Buy: Eli Lilly vs. Johnson & Johnson Motley Fool
07:15AM	Love Dividends? 3 Stocks You Might Want to Buy Motley Fool
06:15AM	This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus Vaccines Motley Fool
Jun-29-20 05:45PM	Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
02:06PM	Race for a COVID-19 vaccine has drug makers scaling up manufacturing before one is developed MarketWatch
11:40AM	J&J (JNJ) Discontinues Phase III Study of Stelara for Lupus Zacks
Jun-27-20 01:15PM	Heres a hedge fund strategy that just might work for you MarketWatch
Jun-26-20 09:42AM	J&J scraps late-stage study testing Stelara for lupus Reuters
09:41AM	Regeneron Used a Charity to Pay Kickbacks, Justice Department Alleges Barrons.com
08:16AM	J&J scraps late-stage study testing Stelara for lupus Reuters
Jun-25-20 06:19PM	Bayer Isnt Out of the Roundup Woods as 30,000 Claims Remain Bloomberg
11:43AM	Moderna Is the Latest Coronavirus Vaccine Partner for Catalent Barrons.com
07:14AM	Vaccine makers face biggest medical manufacturing challenge in history Reuters
07:02AM	Vaccine makers face biggest medical manufacturing feat in history Reuters
07:00AM	INSIGHT-Vaccine makers face biggest medical manufacturing challenge in history Reuters
03:06AM	Unilever, rivals mull changes amid global backlash against skin-lightening products Reuters
Jun-24-20 05:36PM	Johnson & Johnson Option Trader Makes $1.7M Bet On 17% Upside Benzinga
11:05AM	Appeals Court Rules Against J&J but Cuts Talc- Powder Verdict Zacks
02:53AM	Johnson & Johnson Damages Halved To $2.12B By Court In Missouri But Verdict Stands Benzinga
02:05AM	PRESS DIGEST- New York Times business news - June 24 Reuters
01:43AM	PRESS DIGEST - Wall Street Journal - June 24 Reuters
Jun-23-20 04:43PM	How the NACP ETF helps investors align their assets with their values Yahoo Finance Video
01:45PM	J&J Fails To Overturn Baby Powder Verdict, Damages Cut To $2.12B SmarterAnalyst
11:21AM	Johnson & Johnson Baby-Powder Ruling Affirmed, Penalty Cut TheStreet.com
11:05AM	J&J loses bid to overturn baby powder verdict, but damages cut to $2.12 billion Reuters
10:27AM	J&J loses bid to overturn baby powder verdict, but damages cut to $2.1 billion Reuters
10:27AM	Damages verdict against Johnson & Johnson lowered to $2.1 billion in Missouri talc case Reuters
10:08AM	Damages verdict against Johnson & Johnson lowered to $2.1 bln in Missouri talc case Reuters
Jun-20-20 12:11PM	Heres why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies biotech-research team MarketWatch
Jun-19-20 10:33AM	Morning Market Stats in 5 Minutes Benzinga
09:39AM	Johnson & Johnson drops skin-whitening creams Reuters
Jun-18-20 03:15PM	Jeremy Grantham's Top Holdings as of the 1st Quarter GuruFocus.com
12:27PM	Coronavirus update: New case spikes whipsaw market; Fauci warns US may not be ready for football Yahoo Finance
11:40AM	EU In Talks With Johnson & Johnson For Covid-19 Vaccine Deal SmarterAnalyst
11:08AM	Johnson & Johnson in talks with governments on possible COVID-19 vaccine Reuters
10:41AM	EU, Johnson & Johnson In Coronavirus Vaccine Talks: Report Benzinga
06:39AM	Exclusive: EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal - sources Reuters
06:31AM	Exclusive: EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal - sources Reuters
Jun-17-20 11:25AM	Coronavirus update: States struggle to balance reopening with creeping rise in cases Yahoo Finance
09:30AM	2 Strong Buy Healthcare Stocks with Massive Upside Potential Insider Monkey
07:48AM	EU calls for global alliance to buy COVID-19 vaccines up front Reuters
Jun-16-20 12:09PM	The Zacks Analyst Blog Highlights: JNJ, WMT, BAC, IBM and LMT Zacks
10:36AM	U.S. narrows list of promising COVID-19 vaccine candidates to about 7 Reuters
Jun-15-20 05:45PM	Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know Zacks
05:00PM	UK funds human trials of potential COVID-19 vaccine from Imperial Reuters
04:30PM	A Snapshot Of The COVID-19 Data Sharing Ecosystem Benzinga
01:05PM	Top Research Reports for Johnson & Johnson, Walmart & Bank of America Zacks
11:37AM	Germany investing in coronavirus vaccine maker that it accused the Trump administration of trying to poach MarketWatch
09:36AM	Billions or trillions: The great coronavirus trade-off Yahoo Finance Video
08:30AM	3 Rock Solid Dividend Stocks That Won't Flinch if the Market Crashes Again Motley Fool
Jun-13-20 11:37AM	Watch out: This is the age where you should definitely stop trading stocks MarketWatch
10:46AM	Moderna a Step Closer to Coronavirus Vaccine: ETFs to Gain Zacks
08:21AM	Billions or trillions: The great coronavirus trade-off Yahoo Finance
07:50AM	If You Invested $1,000 in Fate Therapeutics' IPO, This Is How Much Money You'd Have Now Motley Fool
Jun-12-20 08:41PM	Dividends Are Down but Not Out. 8 Stocks for the Covid Recession. Barrons.com

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has collaboration agreements with Morphic Therapeutic; and Emergent BioSolutions, Inc. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JOHNSON & JOHNSON	10% Owner	Jun 30	Buy	17.00	725,000	12,325,000	3,670,516	Jul 02 04:58 PM
PEREZ WILLIAM D	Director	Mar 13	Buy	127.69	500	63,843	16,030	Mar 17 04:24 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Option Exercise	90.44	19,224	1,738,619	75,039	Feb 25 04:23 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Sale	147.96	39,224	5,803,583	35,815	Feb 25 04:23 PM
Ullmann Michael H	Exec VP, General Counsel	Feb 13	Option Exercise	0.00	20,326	0	152,697	Feb 18 05:03 PM
Wolk Joseph J	Exec VP, CFO	Feb 13	Option Exercise	0.00	7,080	0	21,387	Feb 18 05:03 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Feb 13	Option Exercise	0.00	15,809	0	65,532	Feb 18 05:03 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13	Option Exercise	0.00	22,231	0	110,559	Feb 18 05:03 PM
Decker Robert J	Controller, CAO	Feb 13	Option Exercise	0.00	1,499	0	13,946	Feb 18 05:03 PM
Duato Joaquin	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	105,668	0	220,373	Feb 18 05:03 PM
Gorsky Alex	Chairman, CEO	Feb 13	Option Exercise	0.00	107,016	0	496,472	Feb 18 05:03 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 13	Option Exercise	0.00	13,747	0	56,496	Feb 18 05:03 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 13	Option Exercise	0.00	3,692	0	57,259	Feb 18 05:03 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Feb 13	Option Exercise	0.00	11,836	0	61,219	Feb 18 05:03 PM
Stoffels Paulus	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	39,381	0	270,900	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 13	Option Exercise	0.00	16,084	0	115,813	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 03	Option Exercise	0.00	48,312	0	123,450	Feb 04 07:31 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 03	Option Exercise	0.00	38,650	0	58,154	Feb 04 07:31 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Option Exercise	62.62	58,128	3,639,975	107,511	Feb 03 06:28 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Sale	149.39	58,128	8,683,568	49,383	Feb 03 06:28 PM
Joly Hubert	Director	Dec 13	Buy	141.28	5,000	706,399	5,000	Dec 16 04:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Option Exercise	62.62	2,017	126,305	51,736	Dec 16 05:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Sale	141.07	2,017	284,538	49,719	Dec 16 05:40 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience